Join
Live feed
·
INSIDERFilingvia Quantisnow
Lyell Immunopharma Inc. logo

Chief Medical Officer Shook David sold $6,350 worth of shares (500 units at $12.70), decreasing direct ownership by 2% to 20,423 units (SEC Form 4) to cover withholding tax

ByQuantisnow·Wall Street's wire, on your screen.
LYEL· Lyell Immunopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LYEL (Lyell Immunopharma Inc.) and more on Quantisnow.

Chief Medical Officer Shook David sold $6,350 worth of shares (500 units at $12.70), decreasing direct ownership by 2% to 20,423 units (SEC Form 4) to cover withholding tax | Quantisnow